Lacosamide 68462-0940-86
- Manufacturer
- Glenmark Pharmaceuticals Limited
- Dosage Form
- Solution
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- September 30, 2024
- Listing Expires
- December 31, 2027
- Application
- ANDA215379
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 10 mg/mL |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
68462-0940-86Selected200 mL in 1 BOTTLE, PLASTIC (68462-940-86)